Oct 12 2009
ChromoCure, Inc. (PINKSHEETS: KKUR) today announced its has executed a Joint Venture Agreement with Sophora Diagnostic Lab, Inc., a profitable New York based cancer pathology lab ("Sophora").
Under the Terms, Sophora will join ChromoCure's pathology lab network and utilize ChromoCure's cancer detection systems as part of its diagnostic operations.
Sophora will market its enhanced diagnostic services to area labs. ChromoCure and Sophora will divide revenues derived from the system equally.
Sophora is ChromoCure's first and flagship installation for its cancer detection system, continuing designs and therapeutic technologies.
Installation, training, and system activation is anticipated to begin immediately. Additional installations of the Company's technology are planned as part of ChromoCure's lab network revenue and growth plan.